Detailed narrative
New Leadership and Strategic Levers
Humana introduced new key executives, including Celeste Mellet as CFO, Michelle O'Hara as CHRO, and Japan Mehta as CIO, aiming to bring fresh perspectives to navigate industry transitions. CEO Jim Rechtin outlined four strategic levers: product experience, clinical excellence, efficient back office, and capital allocation, as fundamental drivers for the business's future success and value creation.
Medicare Advantage Strategy and Membership Mix
The company's 2024 strategy involved repricing Medicare Advantage products to account for elevated medical cost trends, resulting in the shedding of unprofitable plans and resetting expectations in lower-margin offerings. While this led to some membership losses, particularly in the D-SNP space, management views these as largely consistent with their goal of attracting a new member mix focused on sustainable long-term value.
Stars Performance and Clinical Excellence
Humana made significant operational progress in Q4 2024 by closing 650,000 care gaps, a key initiative to improve Stars performance. While the path to an industry-leading Stars position in 2027 remains "tight" and dependent on final thresholds, the company is fully focused on measurement year 2025 (bonus year 2028), leveraging a full year of runway for operating improvements.
Operating Efficiency and Cost Structure
In 2024, Humana improved its operating expense ratio by 40 basis points through various initiatives, including care model optimization, unified shipping, outsourcing noncore capabilities, and streamlining internal distribution. Management believes further efficiencies are achievable and plans to communicate a path for additional improvements in the coming months⏳, aiming for a more flexible and variable cost structure.
Medicaid Growth and Profitability
Humana's Medicaid business is expanding, with an expected member growth of 175,000-250,000 in 2025, driven by new state wins (e.g., Virginia) and additional allocations (e.g., Kentucky). While 45% of 2025 Medicaid members are in states with less than three years of experience, leading to an initial drag on earnings, the performance of mature states like Florida provides a proof point for future margin recovery.
Industry Context and MA Value Proposition
Management reiterated Medicare Advantage's critical role in the U.S. healthcare system, highlighting its ability to deliver better outcomes, operate more efficiently, and provide more affordable access compared to original Medicare. The company expressed openness to partnering constructively to improve the MA program and is internally focused on simplifying healthcare navigation for its members.